Pharmaceutical Business review -

Regulation
Approvals
Metabolic Disorders

October 28, 2026

Arrowhead gains UK marketing authorisation for Redemplo

Arrowhead Pharmaceuticals has received marketing authorisation from the UK Medicines and Healthcare products Regulatory Agency (MHRA) for Redemplo (plozasiran) as an adjunct to diet to reduce triglyceride levels in adults with familial chylomicronaemia syndrome (FCS).

Continue

The regulatory clearance was supported by results from the PALISADE study. Credit: PeopleImages / Shutterstock.com.

October 28, 2026

FDA grants orphan drug status to Octant’s OCT-980 for RP

Ophthalmology
Regulation
Approvals

RP represents a collection of inherited retinal disorders characterised by gradual vision loss that can culminate in total blindness. Credit: luchschenF / Shutterstock.com.

October 27, 2026

Regeneron agrees to $270m extension to supply Ebola medicine in US

Infectious Disease
Pharmaceuticals and Healthcare

Regeneron will supply extra doses of the three-antibody formulation to maintain national emergency stockpiles. Credit: lev radin / Shutterstock.com.

Deals

Drug Discovery

Research & Development

Astellas and AI Proteins sign miniprotein therapeutics deal

Sanofi and ScionxBio partner on mRNA therapies

Clinical Trials

Patient Enrollment

US FDA approves Avacta Group’s IND application for AVA6000

AM-Pharma enrols first patients in Covid-19 phase III trial

Regulation

Drug Filing

Viatris files applications in Japan for approval of Effexor to treat GAD

Scholar Rock submits application of SMA therapy to FDA

Production & Sales

Manufacturing

ENCell and Lucy Biotech forge alliance for mesenchymal stem cell therapy

Merck introduces single-use reactor to accelerate ADC manufacturing

Packaging & Supply Chain

Packaging

Uwe Röhrhoff Steps Down as Interim CEO of Gerresheimer AG

Gerresheimer at CPHI Frankfurt 2025

Suppliers

No data found

Arrowhead gains UK marketing authorisation for Redemplo

FDA grants orphan drug status to Octant’s OCT-980 for RP

Regeneron agrees to $270m extension to supply Ebola medicine in US

Kamada to supply immune globulin products in Latin America

Bavarian Nordic secures $156.8m US vaccine deal

Boehringer Ingelheim receives EC conditional marketing approval for spesolimab

Marinus Pharmaceuticals signs collaboration agreement with Tenacia Biotechnology

Fermion and Simcere to partner on development of pain treatment drug

WuXi Biologics and Sino Biopharm collaborate on monoclonal antibody discovery

Merck enhances ophthalmology portfolio with EyeBio acquisition

Biocon signs licensing and supply deal for diabetes drug in Brazil

Popular

Pharmaceutical Business review is using cookies

Research & Development

Patient Enrollment

Drug Filing

Manufacturing

Packaging

No data found

Contracts

Deals

Popular

PRESS RELEASES

Suppliers

Whitepapers

NEWSLETTER